EGFR and colorectal carcinoma: While we were able to verify the advantage of high target molecule expression for effective ADCC [38,39] and a provides correlation between EGFR and PDL1 expression [40], our comparison of 13 different CRC cell lines provide further insights into cetuximab-mediated ADCC.